Diabetic Neuropathy in Spinal Cord Stimulator Patients

Launched by UNIVERSITY OF CHICAGO · Dec 22, 2020

Keywords

ClinConnect Summary

This clinical trial is studying the effects of Spinal Cord Stimulators (SCS) on patients with painful diabetic neuropathy, a condition caused by diabetes that can lead to severe pain in the lower legs and feet. The goal is to see if using SCS can improve blood circulation and reduce pain, ultimately enhancing the quality of life for those affected by diabetes-related complications.

To participate in this trial, you must be at least 18 years old and have type 2 diabetes for over a year, along with persistent pain in your lower legs. However, there are certain conditions that might exclude you, such as being on blood-thinning medications, having active infections, or severe diabetes complications. If you qualify, you can expect to receive treatment with a Spinal Cord Stimulator and be closely monitored throughout the study to see how it affects your pain and overall health. This research aims to find better ways to help people living with the challenges of diabetes.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Patients with DM type 2 of more than 1-year duration
• • 2. DM stage 3 or less
• • 3. Patients ≥18 years of age
• • 4. Refractory painful diabetic peripheral neuropathy of the lower extremities
• • 5. ABI index \<0.9
• Exclusion Criteria:
• • 1. Patients on anticoagulants
• • 2. Patients with active infections
• • 3. Patients with HbA1\>10
• • 4. Psychiatric disorders and cognitive dysfunctions
• • 5. Illicit Drug Usage
• • 6. Patients on dialysis
• • 7. BMI\>35.0
• • 8. Surgery within the last 30 days
• • 9. Ulcer of the lower extremities
• • 10. Calcification of the peripheral arteries